Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Vicore Pharma Holding AB

Closing information (x1000 EUR)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 9,520 Less Arrow 0 Equal arrow 0
Financial expenses 1 More Arrow 32 More Arrow 43
Earnings before taxes -14,703 Less Arrow -28,057 More Arrow -25,952
EBITDA -16,711 Less Arrow -28,672 More Arrow -25,823
Total assets 104,741 Less Arrow 44,866 Less Arrow 30,374
Current assets 104,741 Less Arrow 44,664 Less Arrow 24,244
Current liabilities 6,347 Less Arrow 3,495 More Arrow 4,160
Equity capital 98,318 Less Arrow 41,041 Less Arrow 25,977
- share capital 10,211 Less Arrow 5,034 Less Arrow 3,677
Employees (average) 27 Less Arrow 25 Less Arrow 21

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 93.9% Less Arrow 91.5% Less Arrow 85.5%
Turnover per employee 353 Less Arrow 0 Equal arrow 0
Profit as a percentage of turnover -154.4%
Return on assets (ROA) -14.0% Less Arrow -62.5% Less Arrow -85.3%
Current ratio 1650.2% Less Arrow 1277.9% Less Arrow 582.8%
Return on equity (ROE) -15.0% Less Arrow -68.4% Less Arrow -99.9%
Change turnover 9,520 Less Arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 2 More Arrow 4 More Arrow 5
Chg. No. of employees % 8% More Arrow 19% More Arrow 31%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.